Skip to content

A Randomised Multi-centre Study to Compare the Short-term Outcomes of Minimally Invasive and Conventional Surgery in Primary Total Hip Replacement

Randomised, Prospective, Post-Market Surveillance Study Comparing the Outcomes of Minimally Invasive and Conventional Surgical Procedures in Subjects Requiring Primary Total Hip Arthroplasty for Osteoarthritis.

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00208416
Enrollment
58
Registered
2005-09-21
Start date
2005-10-31
Completion date
2014-11-30
Last updated
2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis(Primary)

Keywords

Hip, Surgical Technique

Brief summary

The purpose of this study is to compare the short-term outcomes of two surgical techniques, minimally invasive and conventional, when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to undergo surgery using the minimally invasive or conventional surgical technique and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments with a focus on short term rehabilitation.

Interventions

PROCEDUREDePuy MI System

A minimally invasive surgical technique used in total hip replacement.

A conventional surgical technique used in total hip replacement

Sponsors

DePuy International
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

i) Male or female subjects, aged between 18 and 75 years inclusive. ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained. iii) Subjects who in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups. iv) Subjects with a primary diagnosis of osteoarthritis. v) Subjects considered suitable for a primary total hip arthroplasty and are considered suitable for a minimally invasive surgical procedure.

Exclusion criteria

i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study, or extend their time to discharge beyond that required for their hip replacement surgery. ii) Women who are pregnant. iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes. iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s). v) Subjects who are currently involved in any injury litigation claims. vi) Subjects with a Body Mass Index (BMI) \> 30. vii) Subjects with a malunion, arthrodesis or severe dysplasia with superior femoral head migration. viii) Subjects requiring a simultaneous bilateral total hip arthroplasty. ix) Subjects undergoing the second stage of a staged bilateral who are less than 9 months post-arthroplasty

Design outcomes

Primary

MeasureTime frame
Number of hours post-operatively after which subjects are first able to mobilise with a frame or crutchesFirst post-operative day
Level of assistance required to perform 3 functional tasks (supine to sit, sit to stand and bed to chair transfer)on the second post-operative daySecond post-operative day
Time taken (in seconds) for subjects to walk 10 metres on the second post-operative day.Second post-operative day
Amount of time (in seconds) for which subjects are able to stand on the operative leg on the second post-operative day.Second post-operative day

Secondary

MeasureTime frame
Activity levels over specified distancesUntil discharge
Harris Hip score6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery
Haematological parameters assessed over a 56 hours post op56 hours post-operatively
Radiological analysis6weeks, 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery
Oxford Hip score6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery
Pain levels and wound conditionUntil discharge
Trendelenberg signUntil discharge and at 6 weeks
Day of dischargeUntil discharge

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026